Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 16, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Reply: To PMID 22236727

Flavia C L Hoyte, Rohit K Katial

    The Journal of Allergy and Clinical Immunology
    |November 14, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 16, 2026

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
    10:33

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

    Published on: December 17, 2021

    Related Concept Videos

    Chi-square Analysis02:46

    Chi-square Analysis

    The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
    The chi-square test was developed by Pearson in 1990.
    The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Critical flaws in: "Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study".

    The European respiratory journal·2026
    Same author

    Associations Between Social Determinants of Health and Adherence to Biologic Therapies in Patients with Severe Asthma: Real-World Evidence from a Large US Claims Analysis.

    Journal of asthma and allergy·2026
    Same author

    The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

    The journal of allergy and clinical immunology. Global·2026
    Same author

    Asthma remission in the context of other immune-mediated diseases.

    The Journal of allergy and clinical immunology·2025
    Same author

    Current data on biologics: Evaluating clinical remission in asthma.

    The Journal of allergy and clinical immunology·2025
    Same author

    Consensus summary on the definition of asthma remission.

    The Journal of allergy and clinical immunology·2025